This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ROSG (ROSG) (ROSG) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About (ROSG) Stock (NASDAQ:ROSG) 30 days 90 days 365 days Advanced Chart Get (ROSG) alerts:Sign Up Key Stats Today's Range$0.42▼$0.4450-Day Range$0.43▼$0.4352-Week Range$0.23▼$2.75Volume169,599 shsAverage Volume81,512 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewRosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.Read More… Receive ROSG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ROSG) and its competitors with MarketBeat's FREE daily newsletter. Email Address ROSG Stock News Headlinesfarting with DIRECT intense eye contact 👀💨 🤣 #shorts #funny #fartprankOctober 7, 2024 | msn.comWhat is Rosh Hashanah? Here's what to know about the Jewish holidayOctober 3, 2024 | yahoo.comWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. May 25, 2025 | Altimetry (Ad)Insigniam Consultants Join Prestigious CED Fellowship ProgramSeptember 29, 2024 | msn.comThis app’s 52% off and going to make your next vacation so much betterAugust 9, 2024 | nypost.comNvidia's suspected 2025 processor is now rumoured to be built by Intel using off-the-peg Arm cores. Yes, an Nvidia chip built by IntelMay 28, 2024 | msn.comRosetta Genomics Ltd ROSGQFebruary 27, 2024 | morningstar.comLife science company founder: Lowering cost of DNA sequencing leads to groundbreaking advancements in personalized medicineOctober 7, 2023 | bizjournals.comSee More Headlines ROSG Stock Analysis - Frequently Asked Questions How were (ROSG)'s earnings last quarter? (ROSG) (NASDAQ:ROSG) announced its quarterly earnings results on Thursday, May, 19th. The medical research company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.16) by $0.02. The medical research company earned $2.60 million during the quarter, compared to the consensus estimate of $3.36 million. What other stocks do shareholders of (ROSG) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (ROSG) investors own include Agenus (AGEN), Bausch Health Companies (BHC), Endocyte (ECYT), Intercept Pharmaceuticals (ICPT), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT) and (SCMP) (SCMP). Company Calendar Last Earnings5/19/2016Today5/25/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:ROSG CIK1362959 Webwww.rosettagenomics.com Phone972732220700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:ROSG) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ROSG) Please log in to your account or sign up in order to add this asset to your watchlist. Share (ROSG) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.